Latest News

  • PCPs Accelerate Diagnosis, Increase Depth Of Patient Care With Handheld, Wireless Dx Ultrasound

    Diagnostics World News Brief | Healcerion has announced the newly-launched SONON 300L wireless, handheld ultrasound device, which accelerates diagnosis, gains deeper insight into patient health, and provides a richer patient experience, while increasing revenue through the addition of this service to patients.

    Sep 11, 2018
  • Machine Learning Tool Can Spot Mutations In Tumors

    IEEE Spectrum | A new method of identifying unique genetic changes in tumors could lead to more precise cancer treatments.

    Sep 6, 2018
  • The Unleashing Of AI In Real-World Diagnostics

    Diagnostics World | Despite months of speculation about a potential human backlash against artificial intelligence, AI-driven healthcare technologies are already being quietly embraced in real-world healthcare settings around the country.

    Sep 6, 2018
  • Blood-Testing Firm Theranos To Dissolve

    Wall Street Journal | Theranos, the blood-testing company accused of perpetrating Silicon Valley's biggest fraud, will formally dissolve. The move comes after prosecutors filed criminal charges against founder Elizabeth Holmes.

    Sep 5, 2018
  • AI Scramble In Healthcare Well Underway

    Diagnostics World | From point-of-care decision support tools to targeted tumor sequencing tests, artificial intelligence is causing some shakeups within the guarded healthcare industry.

    Sep 4, 2018
  • The Beauty Of Small Data In Medicine From Measuring Kids To Tumor Mutations

    CommonHealth | A big-data informatician writes about a case that marked the beginning of a long education on the value of small data – that is, the clinical impact of a small number of reliable measurements on a single patient.

    Aug 30, 2018
  • Storytelling, Superstores, Search Engines Highlight Health:Further Festival

    Diagnostics World | The first day of the Health:Further festival featured prominent figures in healthcare as they focused on listening to the patient and their story, sometimes in creative ways.

    Aug 29, 2018
  • Exact Sciences, Fuzionaire Dx, Splice Machine, And More: News From August 2018

    Diagnostics World | August featured news, products, and partnerships from around the diagnostics community from numerous companies, universities, and organizations, including Exact Sciences, Fuzionaire Dx, Splice Machine, and more.

    Aug 29, 2018
  • AMP Publishes Recommended Gene Panel For Chronic Myeloid Neoplasms

    Diagnostics World Brief | This week, the Association for Molecular Pathology (AMP) published consensus, evidence-based recommendations to aid clinical laboratory professionals with the management of most Chronic Myeloid Neoplasms (CMNs) and development of high-throughput pan-myeloid sequencing testing panels.

    Aug 23, 2018
  • Study Finds Daxor’s BVA-100 Preferable When Assessing Patients With Heart Failure

    Diagnostics World News Brief | The publication of an investigator-initiated study from Duke University and The Mayo Clinic demonstrated that despite the widespread use of formula-derived estimates of plasma volume in heart failure patients, these methods are inaccurate compared to measured volume using the Daxor’s BVA-100 blood volume measurement diagnostic.

    Aug 22, 2018
  • Facebook Aims To Make MRI Scans 10x Faster With NYU

    Forbes | Facebook and New York University want to train an AI to reconstruct MRI images so that patients don't have to spend as long in MRI scanners.

    Aug 20, 2018
  • MD Anderson Spins Out Neurosciences Company From Discovery Division

    Diagnostics World News Brief | The University of Texas MD Anderson Cancer Center and Accelerator Life Science Partners, a leading life science investment and management firm, have announced the launch of Magnolia Neurosciences Corporation, a company developing a new class of neuroprotective medicines, with $31 million in Series A funding.

    Aug 20, 2018
  • Blood Test Shows Promise Diagnosing Gestational Diabetes Early In Pregnancy

    Diagnostics World Brief | A blood tests commonly used to diagnose Type 2 diabetes could identify women at risk for gestational diabetes as early as the 10th week of pregnancy according to researchers from the National Institute of Child Health and Human Development (NICHD). The results were published today in Scientific Reports.

    Aug 16, 2018
  • Tufts Launches Study Of Targeting Sequencing In Neonatal Diagnosis

    Diagnostics World Brief | Tufts Medical Center has announced an $8 million grant to study the integration of targeted genomic sequencing into neonatal diagnosis and care. The five-year grant is from the National Center For Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH) and will fund a national clinical trial, “Precision Medicine in the Diagnosis of Genetic Disorders in Neonates.”

    Aug 15, 2018